SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-10-000150
Filing Date
2010-11-22
Accepted
2010-11-22 14:59:18
Documents
5
Period of Report
2010-09-30

Document Format Files

Seq Description Document Type Size
1 FROM 10-Q form10-q.htm 10-Q 538147
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) OR 15D-1 exhibit31-1.htm EX-31.1 15060
3 CERTIFICATION OF ACTING PRINCIPAL ACCOUNTING OFFICER PURSUANT TO RULE 13A-14(A) exhibit31-2.htm EX-31.2 15156
4 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350 AS ADOPT exhibit32-1.htm EX-32.1 5618
5 CERTIFICATION OF ACTING PRINCIPAL ACCOUNTING OFFICER PURSUANT TO 18 U.S.C. 1350 exhibit32-2.htm EX-32.2 5624
  Complete submission text file 0001424884-10-000150.txt   581215
Mailing Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6
Business Address UNIT 2 - 3590 WEST 41ST AVENUE VANCOUVER A1 V6N 3E6 604-264-8274
TAPIMMUNE INC (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27239 | Film No.: 101208391
SIC: 2834 Pharmaceutical Preparations